Live Webinar

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Hosted by AJMC, Managed Healthcare Executive, Pharmacy Times and PBMI

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
Opinion|Videos|September 18, 2024

Type 2 Inflammatory Diseases and Impact on Quality of Life

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms and limitations in daily activities.

Episodes in this series
  • How do type 2 inflammatory diseases, such as asthma, eosinophilic esophagitis, or chronic rhinosinusitis with nasal polyps, impact patients’ quality of life?
  • What challenges do patients face in managing their type 2 inflammatory disease(s) on a daily basis?
  • Describe type 2 inflammation. What diseases beyond those mentioned above can it be associated with?
  • What causes this overactive inflammatory response? In your clinical practice, how often do you see patients with type 2 inflammation?

Related Content